[go: up one dir, main page]

WO1999002531A1 - Process for synthesizing carbapenem side chain intermediates - Google Patents

Process for synthesizing carbapenem side chain intermediates Download PDF

Info

Publication number
WO1999002531A1
WO1999002531A1 PCT/US1998/013738 US9813738W WO9902531A1 WO 1999002531 A1 WO1999002531 A1 WO 1999002531A1 US 9813738 W US9813738 W US 9813738W WO 9902531 A1 WO9902531 A1 WO 9902531A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
accordance
formula
produce
reacted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1998/013738
Other languages
French (fr)
Inventor
Karel M. J. Brands
John M. Williams
Ulf H. Dolling
Ronald B. Jobson
Anthony J. Davies
Ian F. Cottrell
Mark Cameron
Michael S. Ashwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810184.3A external-priority patent/GB9810184D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to AU82821/98A priority Critical patent/AU731586B2/en
Priority to CA002294342A priority patent/CA2294342C/en
Priority to JP50875599A priority patent/JP2002504156A/en
Priority to EP98933069A priority patent/EP1019411A4/en
Publication of WO1999002531A1 publication Critical patent/WO1999002531A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings

Definitions

  • the present invention relates to the synthesis of carbapenem side chains, and in particular, to side chains or portions thereof containing a pyrrolidine group, which is bonded to the carbapenem nucleus through a thioether linkage.
  • the pyrrolidine is a portion of the side chain, and is substituted at the two position with any of a variety of substituents.
  • EP 551 993 Al published on July 21, 1993 relates to a synthesis which utilizes active esterifying agents and base, followed by treatment with hydrogen sulfide, or an alkali metal salt of hydrogen sulfide, and base.
  • the present invention is an improvement over these other processes, utilizing a sulfide source which surprisingly improves the process when commercial quantities are synthesized.
  • R! and R2 are independently selected from hydrogen, aryl and heteroaryl, said aryl and heteroaryl groups being unsubstituted or substituted with from 1-3 groups selected from the group consisting of: Cl-4 alkyl, Cl_4 alkoxy, Cl-4 alkyl thio, halo, hydroxy, CO2H, CO2CI-4 alkyl, NH 2 , NHCl-4 alkyl, N(Ci-4 alkyl)2, SO3H, CN, NHC(0)C M alkyl, S0 2 NH 2 , SO2C1-4 alkyl, aryl and heteroaryl;
  • Alkyl and the alkyl portions of substituent groups include monovalent hydrocarbon chains containing from 1-4 carbon atoms which are straight or branched as appropriate.
  • Aryl refers to 6-10 membered mono- and bicyclic ring systems, containing carbon atoms with alternating (resonating) double bonds.
  • Preferred aryl groups are phenyl and naphthyl.
  • Heteroaryl refers to aromatic 5-10 membered mono- and bicyclic ring systems, containing from 1-4 heteroatoms, O, S or N.
  • Preferred nitrogen containing monocyclic heteroaryl groups include pyridyl, pyrimidinyl, pyrazinyl, pyrrolyl, imidazolyl, thiazolyl, oxazolyl and 1, 2, 4-triazolyl.
  • Preferred heteroaryl groups containing oxygen as the only heterotom include furanyl.
  • Preferred heteroaryl groups containing sulfur as the only heterotom include thienyl.
  • Preferred bicyclic heteroaryl groups include benzthiazolyl, benzimidazolyl, quinolinyl and isoquinolinyl, indolyl and isoindolyl.
  • the aryl and heteroaryl groups may be substituted with 1-3 groups selected from the group consisting of: Ci-4 alkyl, Ci-4 alkoxy, C1.4 alkylthio, halo, hydroxy, CO2H, CO2C1-4 alkyl, NH 2 , NHC1-4 alkyl, N(C ⁇ _ 4 alkyl) 2 , NHC(0)Ci- 4 alkyl, SO3H, CN, SO2NH2, SO2C1-4 alkyl, aryl and heteroaryl.
  • Suitable protecting groups include the following without limitation: t-butylmethoxyphenylsilyl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyl- oxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2- trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2-(trimethyl- silyl)ethyl,
  • Preferred silyl protecting groups are trimethylsilyl and triethylsilyl.
  • Preferred carboxyl protecting groups are p-nitrobenzyl and allyl.
  • Preferred phosphoryl based protecting groups include diisopropylphosphoryl.
  • P represents a protecting group on the proline nitrogen atom.
  • P represents a member selected from the group consisting of: t-butylmethoxyphenylsilyl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitro- benzyloxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2-trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2-(trimethylsilyl) ethyl, phen
  • P represents a protecting group which is selected from the group consisting of: t-BOC, diisopropylphosphoryl and p-nitrobenzyloxycarbonyl.
  • P represents diisopropylphosphoryl.
  • Compound 2 used herein as a starting material is N protected trans-4-hydroxy-L-proline.
  • the 2-carboxyl group is activated using the compound diphenylphosphinic chloride, which is reacted with compound II in a solvent in the presence of excess base.
  • Solvents which are useful herein include dichloromethane, acetonitrile, toluene, fluorobenzene, tetrahydrofuran, or mixtures thereof.
  • Bases which are useful for this reaction include trialkylamines.
  • Preferred trialkylamines include diisopropylethylamine (DIPEA) and triethylamine.
  • diphenylphosphinic chloride which is about equimolar to the starting compound
  • the reaction between compound 2 and diphenylphosphinic chloride is typically run at reduced temperature, below about 0°C to as low as about -40°C.
  • the reaction temperature is maintained at about -10°C.
  • Compound 3, with the diphenylphosphinyloxycarbonyl group at position two is reacted with methanesulfonyl chloride (MsCl) to produce compound 4.
  • MsCl methanesulfonyl chloride
  • This reaction is conducted in a solvent, in the presence of a slight molar excess of pyridine, collidine, lutidine and the like, using a slight molar excess of MsCl.
  • This mesylation reaction may be conducted over about 1-4 hours, at a reduced temperature, e.g., about 0°C to as low as about -40°C.
  • the reaction temperature is maintained at about -10°C.
  • Compound 4 is thereafter combined with an alkali metal sulfide or non-alkali metal sulfide and water to form the thiolactone 1.
  • the reaction can be conducted at about -10°C to about room temperature.
  • the sulfide and water are added quickly, and the reaction is aged for several hours at ambient temperature.
  • alkali metal sulfide refers to the group I metal sulfides, such as the sulfides of sodium and potassium.
  • the alkali metal sulfide is Na 2 S.
  • non-alkali metal sulfides and “alkaline earth metals” are used interchangeably to include the group II alkaline earth metal sulfides selected from the group consisting of: magnesium, calcium and barium. Preferred are calcium and barium.
  • the preferred non-alkali metal sulfide most notably CaS, provides an unexpected advantage in that side products of the reaction have low solubility in water, and thus can be removed as a precipitate.
  • the amine HNR'R 2 is m-aminobenzoic acid.
  • the compound of formula 5 is reacted with an acid to produce a compound of formula 6:
  • compound 4' is reacted with a member selected from the group consisting of: Na 2 S, K 2 S, CaS and BaS to produce a compound of formula 1':
  • the thiolactone compound 1 is reacted with the amine HNR'R 2 in the presence of an organic acid to produce compound 5.
  • organic acids include formic acid, acetic acid and propionic acid. Most preferably, the reaction is conducted in the presence of acetic acid.
  • compound 4' After the conversion of compound 4' to compound 1', the latter is combined with ammonia or a primary or secondary amine to form compounds of formula 5', which can be deprotected to give compound 6' or salt thereof.
  • solvents such as C,_ 5 alcohols, C j . 3 alkanoic acids, toluene, acetonitrile, ethyl acetate and others may be added to improve crystallization, or otherwise facilitate isolation.
  • addition of a trialkyl or triaryl phosphine, e.g., tri-n-butylphosphine, at this stage may be useful in reducing the formation of disulfides corresponding to compound 6' and/or improving the rejection of other impurities.
  • HNR*R 2 wherein R 1 and/or R 2 represent H, aryl or heteroaryl react with compound 1 upon slight heating. Generally, the reaction proceeds from about RT to about 100°C over a few minutes to several hours.
  • the acid that is used to convert compound 5' to compound 6' can be varied within wide limits.
  • concentrated HCl can be used and is preferred.
  • the invention described herein can be conducted in essentially a single reaction vessel, thus allowing for economical production of compounds 6' from compound 2.
  • the mesylate mixed anhydride was formed according to WO 97/06154 published on February 20, 1997, incorporated herein by reference, and stirred with cooling at -15°C for 15 min.
  • Example One Part B
  • the compounds of column one are reacted with methanesulfonyl chloride to produce the compounds in column two.
  • Example Three Using the procedures set forth in Example Three, the compounds of column one are reacted with the amine in column two to produce the compounds in column three.
  • Tri-n-butylphosphine may be added.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

A process of synthesizing a compound of formula (1) is described. A compound of formula (2) is reacted with diphenylphosphinic chloride to activate the carboxylic acid group, and then reacted with methanesulfonyl chloride to produce a compound of formula (4). Compound (4) is then reacted with a group II metal sulfide source in water to produce a compound of formula (1).

Description

TITLE OF THE INVENTION
PROCESS FOR SYNTHESIZING CARBAPENEM
SIDE CHAIN INTERMEDIATES
BACKGROUND OF THE INVENTION
The present invention relates to the synthesis of carbapenem side chains, and in particular, to side chains or portions thereof containing a pyrrolidine group, which is bonded to the carbapenem nucleus through a thioether linkage. Typically, the pyrrolidine is a portion of the side chain, and is substituted at the two position with any of a variety of substituents.
Conventionally, these intermediate compounds are prepared from a 4-hydroxyproline derivative of the formula:
Figure imgf000003_0001
Such synthetic schemes typically require the extensive use of protecting groups.
Similarly, a method of converting trans-4-hydroxy-L-proline to a thiolactone of the formula:
Figure imgf000003_0002
has been described. However, this thiolactone is unsuitably protected for synthesis of carbapenem antibiotics. EP 551 993 Al published on July 21, 1993 relates to a synthesis which utilizes active esterifying agents and base, followed by treatment with hydrogen sulfide, or an alkali metal salt of hydrogen sulfide, and base. The present invention is an improvement over these other processes, utilizing a sulfide source which surprisingly improves the process when commercial quantities are synthesized.
SUMMARY OF THE INVENTION A process for synthesizing a compound of the formula 1:
Figure imgf000004_0001
is described wherein P is a protecting group
comprising
(a) reacting a compound of formula 2:
Figure imgf000004_0002
wherein P is as previously defined with diphenylphosphinic chloride to produce a compound of formula 3:
Figure imgf000005_0001
(b) reacting compound 3 with methanesulfonyl chloride to produce a compound of formula 4:
Figure imgf000005_0002
(c) combining compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of formula 1.
More particularly, the process described herein relates to a process for producing a compound of the formula 5:
Figure imgf000005_0003
wherein P is a protecting group;
R! and R2 are independently selected from hydrogen, aryl and heteroaryl, said aryl and heteroaryl groups being unsubstituted or substituted with from 1-3 groups selected from the group consisting of: Cl-4 alkyl, Cl_4 alkoxy, Cl-4 alkyl thio, halo, hydroxy, CO2H, CO2CI-4 alkyl, NH2, NHCl-4 alkyl, N(Ci-4 alkyl)2, SO3H, CN, NHC(0)CM alkyl, S02NH2, SO2C1-4 alkyl, aryl and heteroaryl;
comprising: (a) reacting a compound of the formula 2:
Figure imgf000006_0001
wherein P is as previously defined with diphenylphosphinic chloride to produce a compound of the formula 3:
Figure imgf000006_0002
(b) reacting compound 3 with methanesulfonyl chloride to produce a compound of formula 4:
Figure imgf000007_0001
(c) combining compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of formula 1:
Figure imgf000007_0002
and
(d) reacting compound 1 with NHR*R2 wherein R1 and R2 are as previously defined to produce a compound of formula 5.
DETAILED DESCRIPTION OF THE INVENTION
The invention is described using the following definitions unless otherwise specified.
Alkyl and the alkyl portions of substituent groups include monovalent hydrocarbon chains containing from 1-4 carbon atoms which are straight or branched as appropriate.
Aryl refers to 6-10 membered mono- and bicyclic ring systems, containing carbon atoms with alternating (resonating) double bonds. Preferred aryl groups are phenyl and naphthyl.
Heteroaryl refers to aromatic 5-10 membered mono- and bicyclic ring systems, containing from 1-4 heteroatoms, O, S or N. Preferred nitrogen containing monocyclic heteroaryl groups include pyridyl, pyrimidinyl, pyrazinyl, pyrrolyl, imidazolyl, thiazolyl, oxazolyl and 1, 2, 4-triazolyl. Preferred heteroaryl groups containing oxygen as the only heterotom include furanyl. Preferred heteroaryl groups containing sulfur as the only heterotom include thienyl.
Preferred bicyclic heteroaryl groups include benzthiazolyl, benzimidazolyl, quinolinyl and isoquinolinyl, indolyl and isoindolyl. When substituted, the aryl and heteroaryl groups may be substituted with 1-3 groups selected from the group consisting of: Ci-4 alkyl, Ci-4 alkoxy, C1.4 alkylthio, halo, hydroxy, CO2H, CO2C1-4 alkyl, NH2, NHC1-4 alkyl, N(Cι_4 alkyl)2, NHC(0)Ci-4 alkyl, SO3H, CN, SO2NH2, SO2C1-4 alkyl, aryl and heteroaryl.
When necessary, the substituents which are optionally present on aryl and heteroaryl can be in protected form. Examples of suitable protecting groups include the following without limitation: t-butylmethoxyphenylsilyl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyl- oxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2- trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2-(trimethyl- silyl)ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl, 4-pyridylmethyl, t-butyl, allyloxycarbonyl, di- .^ alkylphosphoryl, diarylphosphoryl and di-ar-C 0 alkylphosphoryl. Preferred silyl protecting groups are trimethylsilyl and triethylsilyl. Preferred carboxyl protecting groups are p-nitrobenzyl and allyl. Preferred phosphoryl based protecting groups include diisopropylphosphoryl.
Many other suitable hydroxyl and carboxyl protecting groups are known in the art. See, e.g., Greene, T. W., et al. Protective Groups in Organic Synthesis, John Wiley & Sons, Inc., 1991.
P represents a protecting group on the proline nitrogen atom. Thus, in one aspect of the invention, P represents a member selected from the group consisting of: t-butylmethoxyphenylsilyl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitro- benzyloxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2-trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2-(trimethylsilyl) ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl, 4-pyridylmethyl, t-butyl, allyloxycarbonyl, di-C,.l0 alkylphosphoryl, diarylphosphoryl and di-ar-C,.10 alkylphosphoryl.
More particularly, P represents a protecting group which is selected from the group consisting of: t-BOC, diisopropylphosphoryl and p-nitrobenzyloxycarbonyl.
Most particularly, P represents diisopropylphosphoryl. Compound 2 used herein as a starting material is N protected trans-4-hydroxy-L-proline. The 2-carboxyl group is activated using the compound diphenylphosphinic chloride, which is reacted with compound II in a solvent in the presence of excess base. Solvents which are useful herein include dichloromethane, acetonitrile, toluene, fluorobenzene, tetrahydrofuran, or mixtures thereof. Bases which are useful for this reaction include trialkylamines. Preferred trialkylamines include diisopropylethylamine (DIPEA) and triethylamine. Typically an amount of diphenylphosphinic chloride which is about equimolar to the starting compound can be used. The reaction between compound 2 and diphenylphosphinic chloride is typically run at reduced temperature, below about 0°C to as low as about -40°C. Preferably, the reaction temperature is maintained at about -10°C. Compound 3, with the diphenylphosphinyloxycarbonyl group at position two, is reacted with methanesulfonyl chloride (MsCl) to produce compound 4. This reaction is conducted in a solvent, in the presence of a slight molar excess of pyridine, collidine, lutidine and the like, using a slight molar excess of MsCl. This mesylation reaction may be conducted over about 1-4 hours, at a reduced temperature, e.g., about 0°C to as low as about -40°C. Preferably, the reaction temperature is maintained at about -10°C.
Compound 4 is thereafter combined with an alkali metal sulfide or non-alkali metal sulfide and water to form the thiolactone 1. Essentially the reaction can be conducted at about -10°C to about room temperature. Preferably the sulfide and water are added quickly, and the reaction is aged for several hours at ambient temperature.
As used herein, "alkali metal sulfide" refers to the group I metal sulfides, such as the sulfides of sodium and potassium. Preferably the alkali metal sulfide is Na2S.
As used herein, "non-alkali metal sulfides" and "alkaline earth metals" are used interchangeably to include the group II alkaline earth metal sulfides selected from the group consisting of: magnesium, calcium and barium. Preferred are calcium and barium.
The preferred non-alkali metal sulfide, most notably CaS, provides an unexpected advantage in that side products of the reaction have low solubility in water, and thus can be removed as a precipitate.
In a preferred aspect of the process described herein, the amine HNR'R2 is m-aminobenzoic acid.
In another preferred aspect of the process, the compound of formula 5 is reacted with an acid to produce a compound of formula 6:
Figure imgf000010_0001
6
More particularly, a compound of formula 2':
Figure imgf000010_0002
2'
is reacted with diphenylphosphinic chloride to produce a compound of formula 3':
Figure imgf000011_0001
compound 3' is reacted with mesyl chloride to produce compound 4':
Figure imgf000011_0002
4'
compound 4' is reacted with a member selected from the group consisting of: Na2S, K2S, CaS and BaS to produce a compound of formula 1':
Figure imgf000011_0003
compound 1' is reacted with m-aminobenzoic acid to produce 5' :
Figure imgf000012_0001
5'
and compound 5' is reacted with acid to produce a compound of formula 6':
Figure imgf000012_0002
or a salt or solvate thereof.
In a preferred aspect of the invention, the thiolactone compound 1 is reacted with the amine HNR'R2 in the presence of an organic acid to produce compound 5. Examples of suitable organic acids include formic acid, acetic acid and propionic acid. Most preferably, the reaction is conducted in the presence of acetic acid.
After the conversion of compound 4' to compound 1', the latter is combined with ammonia or a primary or secondary amine to form compounds of formula 5', which can be deprotected to give compound 6' or salt thereof. In the isolation of 6' solvents, such as C,_5 alcohols, Cj.3 alkanoic acids, toluene, acetonitrile, ethyl acetate and others may be added to improve crystallization, or otherwise facilitate isolation. Also, addition of a trialkyl or triaryl phosphine, e.g., tri-n-butylphosphine, at this stage may be useful in reducing the formation of disulfides corresponding to compound 6' and/or improving the rejection of other impurities.
Most primary and secondary amines HNR*R2 wherein R1 and/or R2 represent H, aryl or heteroaryl react with compound 1 upon slight heating. Generally, the reaction proceeds from about RT to about 100°C over a few minutes to several hours.
The acid that is used to convert compound 5' to compound 6' can be varied within wide limits. For example, concentrated HCl can be used and is preferred.
The invention described herein can be conducted in essentially a single reaction vessel, thus allowing for economical production of compounds 6' from compound 2.
The invention is further illustrated with the following non- limiting examples.
EXAMPLE ONE
QS. 4SV5-DIISOPROPYLPHOSPHORYL-2-THIA-5-
AZABICYCLOr2.2.11HEPTAN-3-ONE
diphenylphosphinic chloride
Figure imgf000013_0001
1-2
methanesulfonyl chloride
Figure imgf000013_0002
Figure imgf000014_0001
Figure imgf000014_0002
The following starting materials were utilized:
Figure imgf000014_0003
The mesylate mixed anhydride was formed according to WO 97/06154 published on February 20, 1997, incorporated herein by reference, and stirred with cooling at -15°C for 15 min.
Calcium sulfide (1.49 g) was added as a solid and washed with water (30 mL), resulting in a three phase reaction mixture. The mixture was stirred rapidly and the cooling bath removed, allowing the mixture to reach room temperature. The solids quickly went into solution, and a white solid precipitate was formed.
The mixture was stirred for 45 min and then filtered through a coarse filter. The solid on the filter was washed with dichloromethane and the filtrate separated.
The organic layer (approx. 200 mL) was washed with 1 M HCl (50 mL), and 8% NaHC03 (50 mL). The aqueous bicarbonate layer was back extracted and the combined extracts were washed with brine and the layers weighed. The presence of the title compound (4.04 g) was confirmed by HPLC.
EXAMPLE TWO
diphenylphosphinic chloride
Figure imgf000015_0001
2-2
methanesulfonyl chloride
Figure imgf000015_0002
Figure imgf000016_0001
2-4
Figure imgf000016_0002
A. Synthesis of transrN-t-butoxycarbonyl-2- diphenylphosphinyloxycarbonyl-4-hydroxy-L-proline
inic
Figure imgf000016_0003
2-2
Figure imgf000016_0004
2-3
A solution of compound 2-2 (35.0 g, 151 mmol.) and DIPEA (60 mL, 344 mmol) in dry THF (1.0 L) was combined over 20 min with a solution of diphenylphosphinic chloride (37.5 g, 155 mmol) in THF (50 mL) at -20°C. The reaction mixture was stirred at -20°C for 90 minutes to produce compound 2-3, which can be isolated and characterized or used in the next part without isolation.
B. Synthesis of trans-N-t-butoxycarbonyl-2-diphenylphosphinyl oxycarbonyl-4-methanesulfonyloxy-L-proline
methanesulfonyl chloride
Figure imgf000017_0001
2-3
Figure imgf000017_0002
2-4
Without isolation and characterization, after stirring the reaction mixture from part A for 90 minutes at -20°C, pyridine (13.0 mL, 161 mmol) was added followed by a solution of methanesulfonyl chloride (19.8 g, 171 mmol) in THF (50 mL) over 15 minutes. The reaction mixture was stirred at -20°C for 2 hours and allowed to warm to -5°C over an additional 30 minutes producing compound 2-4. The methanesulfonyl substituted compound can be isolated and characterized, or used in the next reaction without isolation and characterization. Synthesis of N-t-butoxycarbonyl-2-thia-5-azabicyclo[2.2. l]heptan- 3-one
Figure imgf000018_0001
2-4
Figure imgf000018_0002
After allowing the reaction from part B to warm to -5°C, a slurry of CaS (45.0 g, 187 mmol) in H2O (60 mL) is added in one portion. The mixture is allowed to warm to room temperature and is stirred for 6 hrs. The resulting suspension is filtered and the filtrate is then partitioned between toluene and water. The organic layer is washed with HCl (2.0 M), NaHCθ3 (1.0 M) and brine, dried over MgS04 and concentrated in vacuo.
EXAMPLE THREE
Figure imgf000018_0003
3-5 The thiolactone 2-1 from Example Two without isolation, can be combined with the amine shown below in column one to produce the cis N-protected 4-thiol substituted proline derivative shown below in column two.
Figure imgf000019_0001
Figure imgf000020_0001
(1) 4.0 eq. of NH4C1 in Et3N; solvent CH3OH; reaction time: 30 min at RT;
(2) 1.25 eq. of aniline; solvent toluene; reaction time: 2 hrs at l00°C;
(3) 1.25 eq. of 3-aminobenzoic acid; solvent toluene; reaction time: 2 hrs at 100°C;
(4) 1.25 eq. of 5-amino-2-carboxythiophene; solvent toluene; 2 hrs at 100°C;
(5) P represents diisopropylphosphoryl. (iPr = isopropyl).
EXAMPLE FOUR
Using the procedures set forth in Example Two, Part A, the compounds of column one are reacted with diphenylphosphinic chloride to produce the compounds in column two.
Figure imgf000021_0001
EXAMPLE FIVE
Using the procedures set forth in Example One, Part B, the compounds of column one are reacted with methanesulfonyl chloride to produce the compounds in column two.
Figure imgf000022_0001
Figure imgf000023_0002
EXAMPLE SIX
Using the procedures set forth in Example Two, Part C, the compounds of column one are reacted with CaS in water to produce the compounds in column two.
Figure imgf000023_0001
Figure imgf000024_0001
EXAMPLE SEVEN
Using the procedures set forth in Example Three, the compounds of column one are reacted with the amine in column two to produce the compounds in column three.
Figure imgf000025_0001
Figure imgf000026_0001
Figure imgf000027_0001
Figure imgf000028_0001
1 : Tri-n-butylphosphine may be added.
While certain preferred embodiments have been described herein in detail, numerous alternative embodiments are contemplated as falling within the scope of the invention.

Claims

WHAT IS CLAIMED IS:
1. A process for synthesizing a compound of the formula 1:
Figure imgf000029_0001
wherein P is a protecting group,
comprising (a) reacting a compound of the formula 2:
Figure imgf000029_0002
wherein P is as previously defined with diphenylphosphinic chloride to produce a compound of the formula 3:
Figure imgf000029_0003
(b) reacting compound 3 with methanesulfonyl chloride to produce a compound of formula 4:
Figure imgf000030_0001
4 , and
(c) combining compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of formula 1.
2. A process of producing a compound of the formula 5:
Figure imgf000030_0002
wherein P is a protecting group;
R! and R2 are independently selected from hydrogen, aryl and heteroaryl, said aryl and heteroaryl groups being unsubstituted or substituted with from 1-3 groups selected from the group consisting of: Cl-4 alkyl, Cl-4 alkoxy, Cl-4 alkylthio, halo, hydroxy, CO2H, CO2CI-4 alkyl, NH2, NHCl-4 alkyl, N(Cl-4 alkyl)2, SO3H, CN, NHC(0)C alkyl, SO2NH2, SO2C1-4 alkyl, aryl and heteroaryl;
comprising: (a) reacting a compound of the formula 2:
Figure imgf000031_0001
wherein P is as previously defined with diphenylphosphinic chloride to produce a compound of the formula 3:
Figure imgf000031_0002
(b) reacting compound 3 with methanesulfonyl chloride to produce a compound of formula 4:
Figure imgf000031_0003
(c) combining compound 4 with an alkali metal sulfide or non- alkali metal sulfide in water to produce a compound of formula 1:
Figure imgf000032_0001
and (d) reacting compound 1 with NHR lR2 wherein R1 and R2 are as previously defined to produce a compound of formula 5.
3. A process in accordance with claim 1 wherein P represents a member selected from the group consisting of: t-butylmethoxyphenylsil'yl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2- trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2- (trimethylsilyl)ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl, 4-pyridylmethyl, t-butyl, allyloxycarbonyl, di-C 0 alkylphosphoryl, diarylphosphoryl and di-ar-C 0 alkylphosphoryl.
4. A process in accordance with claim 3 wherein P is selected from t-BOC, p-nitrobenzyloxycarbonyl and diisopropylphosphoryl.
5. A process in accordance with claim 4 wherein
P represents diisopropylphosphoryl.
6. A process in accordance with claim 2 wherein 1 and NHR'R2 are reacted to produce a compound of formula 5 in the presence of an organic acid.
7. A process in accordance with claim 6 wherein the organic acid is selected from formic acid, acetic acid and propionic acid.
8. A process in accordance with claim 6 wherein 1 and
NHR!R2 are reacted in an organic solvent.
9. A process in accordance with claim 8 wherein the organic solvent is methylene chloride.
10. A process in accordance with claim 1 wherein compound 2 is reacted with diphenylphosphinic chloride in the presence of a base.
11. A process in accordance with claim 3 wherein the base is a trialkylamine.
12. A process in accordance with claim 11 wherein the trialkylamine is selected from the group consisting of diisopropylethylamine and triethylamine.
13. A process in accordance with claim 1 wherein compound 3 is reacted with methanesulfonyl chloride to produce a compound of formula 4 in the presence of a base.
14. A process in accordance with claim 13 wherein the base is selected from the group consisting of pyridine, collidine and lutidine.
15. A process in accordance with claim 1 wherein compound 4 is reacted with a non-alkali metal sulfide to produce a compound of formula 1.
16. A process in accordance with claim 15 wherein the non-alkali metal sulfide in water is reacted with compound 4 to produce a compound of formula 1 at a temperature of about -10°C to about room temperature.
17. A process in accordance with claim 1 wherein P represents t-butoxycarbonyl, diisopropylphosphoryl or p-nitrobenzyloxycarbonyl.
18. A process in accordance with claim 2 wherein compound 2 is reacted with diphenylphosphinic chloride in the presence of a base.
19. A process in accordance with claim 18 wherein the base is a trialkylamine. -
20. A process in accordance with claim 19 wherein the trialkylamine is selected from the group consisting of diisopropylethylamine and triethylamine.
21. A process in accordance with claim 2 wherein compound 3 is reacted with methanesulfonyl chloride to produce a compound of formula 4 in the presence of a base.
22. A process in accordance with claim 19 wherein the base is selected from the group consisting of pyridine, collidine and lutidine.
23. A process in accordance with claim 1 wherein the non-alkali metal sulfide in water is reacted with compound 4 to produce a compound of formula 1 at a temperature of about -10°C to about room temperature.
24. A process in accordance with claim 2 wherein P represents t-butoxycarbonyl, diisopropylphosphoryl or p- nitrobenzyloxycarbonyl.
25. A process in accordance with claim 2 wherein NHRiR2 is selected from the group consisting of:
Figure imgf000035_0001
26. A process in accordance with claim 15 wherein the non-alkali metal sulfide is selected from a sulfide of calcium, barium and magnesium.
27. A process in accordance with claim 26 wherein the non-alkali metal sulfide is comprised of calcium sulfide.
28. A process in accordance with claim 26 wherein the non-alkali metal sulfide is comprised of barium sulfide.
29. A process in accordance with claim 1 wherein: P represents diisopropylphosphoryl and compound 4 is reacted with CaS in water to produce a compound of formula 1.
30. A process in accordance with claim 1 wherein:
P represents diisopropylphosphoryl and compound 4 is reacted with NajS in water to produce a compound of formula 1.
31. A process in accordance with claim 2 wherein the amine HNR!R2 is m-aminobenzoic acid.
32. A process in accordance with claim 2, further comprising reacting a compound of formula 5 with an acid to produce a compound of formula 6:
Figure imgf000036_0001
H 6
33. A process in accordance with claim 32 in which trialkyl or triarylphosphines is optionally added.
34. A process in accordance with claim 33 in which the trialkylphosphine is tri-n-butylphosphine.
35. A process in accordance with claim 32 in which a solvent selected from the group consisting of C 5 alcohols, Cj.3 alkanoic acids, toluene, acetonitrile, ethyl acetate and others is optionally added.
36. A process in accordance with claim 2, wherein a compound of formula 2' :
Figure imgf000036_0002
2'
is reacted with diphenylphosphinic chloride to produce a compound of formula 3':
Figure imgf000037_0001
compound 3 ' is reacted with mesyl chloride to produce a compound of formula 4' :
Figure imgf000037_0002
P(O)(OiPr)2
4'
compound 4' is reacted with a member selected from the group consisting of: Na2S, K2S, CaS and BaS to produce a compound of formula 1':
Figure imgf000037_0003
compound 1' is reacted with m-aminobenzoic acid to produce 5':
Figure imgf000038_0001
5'
and compound 5' is reacted with acid to produce a compound of formula
6' :
Figure imgf000038_0002
or a salt or solvate thereof.
37. A process in accordance with claim 32 in which trialkyl or triarylphosphines is optionally added.
38. A process in accordance with claim 33 in which the trialkylphosphine is tri-n-butylphosphine.
39. A process in accordance with claim 32 in which a solvent selected from the group consisting of Ct.5 alcohols, C 3 alkanoic acids, toluene, acetonitrile, ethyl acetate and others is optionally added.
PCT/US1998/013738 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates Ceased WO1999002531A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU82821/98A AU731586B2 (en) 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates
CA002294342A CA2294342C (en) 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates
JP50875599A JP2002504156A (en) 1997-07-09 1998-07-02 Synthetic process of carbapenem side chain intermediate
EP98933069A EP1019411A4 (en) 1997-07-09 1998-07-02 METHOD FOR SYNTHETIZING SIDE CHAIN CARBAPENEM INTERMEDIATES

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5203297P 1997-07-09 1997-07-09
US60/052,032 1997-07-09
GBGB9810184.3A GB9810184D0 (en) 1998-05-13 1998-05-13 Process for synthisizing carbapenem side chain intermediates
GB9810184.3 1998-05-13

Publications (1)

Publication Number Publication Date
WO1999002531A1 true WO1999002531A1 (en) 1999-01-21

Family

ID=26313663

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/013738 Ceased WO1999002531A1 (en) 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates

Country Status (5)

Country Link
EP (1) EP1019411A4 (en)
JP (1) JP2002504156A (en)
AU (1) AU731586B2 (en)
CA (1) CA2294342C (en)
WO (1) WO1999002531A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064684A1 (en) * 2000-03-01 2001-09-07 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US7091363B2 (en) * 2000-11-20 2006-08-15 Sankyo Company, Limited Compounds for the preparation of carbapenem-type antibacterial agents
WO2006020573A3 (en) * 2004-08-11 2009-04-16 Donald L Barbeau Noncardiotoxic pharmaceutical compounds
EP0998457A4 (en) * 1997-07-10 2010-03-10 CRYSTALLINE FORMS OF ANTIBIOTIC LATERAL CHAIN INTERMEDIATES
WO2010073706A1 (en) * 2008-12-25 2010-07-01 株式会社カネカ Improved process for producing intermediate for side chain of carbapenem
CN106565579A (en) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 Ertapenem side chain production technology
CN117304203A (en) * 2023-09-28 2023-12-29 郑州原理生物科技有限公司 Preparation method of meropenem side chain intermediate thiolactone

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340738A (en) * 1979-06-21 1982-07-20 Janssen Pharmaceutica, N.V. 2,3-Dihydro-imidazo[2,1-b]benzothiazoles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
JP3091297B2 (en) * 1992-01-10 2000-09-25 住友製薬株式会社 Pyrrolidine derivative and method for producing the same
CA2227696C (en) * 1995-08-04 2003-09-23 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340738A (en) * 1979-06-21 1982-07-20 Janssen Pharmaceutica, N.V. 2,3-Dihydro-imidazo[2,1-b]benzothiazoles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1019411A4 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0998457A4 (en) * 1997-07-10 2010-03-10 CRYSTALLINE FORMS OF ANTIBIOTIC LATERAL CHAIN INTERMEDIATES
WO2001064684A1 (en) * 2000-03-01 2001-09-07 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US7091363B2 (en) * 2000-11-20 2006-08-15 Sankyo Company, Limited Compounds for the preparation of carbapenem-type antibacterial agents
WO2006020573A3 (en) * 2004-08-11 2009-04-16 Donald L Barbeau Noncardiotoxic pharmaceutical compounds
US8088918B2 (en) 2004-08-11 2012-01-03 Williamsburg Holdings Llc Noncardiotoxic pharmaceutical compounds
WO2010073706A1 (en) * 2008-12-25 2010-07-01 株式会社カネカ Improved process for producing intermediate for side chain of carbapenem
CN106565579A (en) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 Ertapenem side chain production technology
CN117304203A (en) * 2023-09-28 2023-12-29 郑州原理生物科技有限公司 Preparation method of meropenem side chain intermediate thiolactone

Also Published As

Publication number Publication date
EP1019411A1 (en) 2000-07-19
AU8282198A (en) 1999-02-08
AU731586B2 (en) 2001-04-05
CA2294342C (en) 2006-03-14
CA2294342A1 (en) 1999-01-21
EP1019411A4 (en) 2003-08-13
JP2002504156A (en) 2002-02-05

Similar Documents

Publication Publication Date Title
US4631150A (en) Process for the preparation of penems
KR20010086058A (en) IMIDAZO[4,5-b]PYRIDINIUMMETHYL-CONTAINING CEPHEM COMPOUNDS HAVING BROAD ANTIBACTERIAL SPECTRUM
SU856388A3 (en) Method of preparing unsaturated derivatives of 7-acylamido-3-cephem-4-carboxalic acid or their esters or their alkaline metal salts
CA2294342C (en) Process for synthesizing carbapenem side chain intermediates
CA2657930A1 (en) Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile
EP0842166B1 (en) Process for synthesizing carbapenem side chain intermediates
US6063931A (en) Process for synthesizing carbapenem side chain intermediates
EP0557122B1 (en) A production method for sulfamide
JPH08193076A (en) Method for synthesizing N-acyl auxiliary
US6060607A (en) Process for synthesizing carbapenem side chain intermediates
KR950013578B1 (en) Novel thiophosphate derivatives of novel thi (diazo) acetic acid and preparation method thereof
US5648501A (en) Process for synthesizing carbapenem side chain intermediates
GB2257703A (en) Acylation of 7 - amino-cephems
US5721368A (en) Process for synthesizing carbapenem side chain intermediates
KR101059339B1 (en) Method for preparing carbapenem compound for oral administration
PL145176B1 (en) Process for preparing derivatives of penemo-2-carboxylic-3-acid
US4841043A (en) Stereoselective synthesis of 1-β-alkyl carbapenem antibiotic intermediates
AU661192B2 (en) 4-substituted alkyl carbapenem antibiotics
JP2696807B2 (en) Preparation of carbapenem derivatives
KR950010083B1 (en) Process for preparing cephalosporin compounds
WO1991017995A1 (en) New penem dithiocarbamates, their use and production methods
KR100650207B1 (en) Glutaryl 7-amino-3-vinyl-cephalosporanic acid derivatives and process for preparing it
US20060281918A1 (en) Resolution of enantiomeric mixtures of beta-lactams
IE880488L (en) Benzoindazoles
JPS63310890A (en) 6-amino-substituted-1-methylcarbapenem derivative

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GE GW HR HU ID IL IS JP KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA US UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2294342

Country of ref document: CA

Ref country code: CA

Ref document number: 2294342

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998933069

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 82821/98

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1998933069

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 82821/98

Country of ref document: AU